Joint Statement from the California Department of Justice, California State Board of Pharmacy, and the Medical Board of California Regarding Secure Prescription Forms

Joint Statement from the California Department of Justice, California State Board of Pharmacy, and the Medical Board of California Regarding Secure Prescription Forms As of January 1, 2019, California law requires prescription forms for controlled substances to be printed with a uniquely serialized number.  Notices explaining the serial number format and reporting requirements have been[…]

New Policies Regarding Written Prescriptions

The Department of Justice has implemented new policies regarding written prescriptions for controlled substances, in a continued effort to combat drug abuse. As of January 1, 2019, all written prescriptions for Schedule II, III, IV, or V controlled substances must be done so on an approved security prescription form that is compliant with their new[…]

Compounded Flavored Pet Liquid Medication

Board of Pharmacy Update

On April 18th, the Board of Pharmacy Enforcement and Compounding Sub-Committee met. On the agenda was a discussion of how the new compounding laws have been affecting veterinary practice. Primarily at issue was the Beyond Use Date updates that require cGMP level testing in order to extend Beyond Use Dates beyond 14 days for most[…]

New Location GGVCP

(Part III) Compounded and Handling of Hazardous Drugs – New Regulations

In February of last year, the Compounding Expert Committee and the Compounding with Hazardous Drugs Expert Panel released a revised USP Chapter 800 that outlines the standards that should be maintained while handling hazardous drugs (HDs) in healthcare settings. Whereas these standards will not necessarily impact your daily operations, they do impact compounding pharmacies and[…]